Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
AMYPAD presents at NRM2021
AMYPAD presents at NRM2021 17 Dec 2021 The NRM 2021 conference offered an exciting scientific and virtual social program for discussing the latest research involving PET neuroreceptors......
Recruitment update
Recruitment update 30 Nov 2021 AMYPAD PHNS: currently 1.155 participants recruited of which 1.163 have been scanned......
Welcome to the 19th issue of the AMYPAD newsletter
Welcome to the 19th issue of the AMYPAD newsletter 19 Nov 2021 We have now entered the final (6th) year of AMYPAD, and I hope you enjoyed the general assembly meeting in early October like I did......
Recruitment status (as 30 November, 2021)
Recruitment status (as 30 November, 2021)